Linked Life Data

15863142

Source:http://linkedlifedata.com/resource/pubmed/id/15863142

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-5-2
pubmed:abstractText
Mucinous epithelial ovarian cancer (mEOC) representing about 10% of all EOC are known to be possibly resistant to platinum-based chemotherapy and bear a poorer prognosis with respect to other subtypes of EOC. This study was undertaken to compare response and survival to platinum-based chemotherapy between patients with advanced stages III and IV mEOC and serous EOC (sEOC).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0090-8258
pubmed:author
pubmed:issnType
Print
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
436-41
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
pubmed:affiliation
Second Department of Internal Medicine-Propaedeutic, Oncology Section, University General Hospital ATTIKON, Gravias 5B, Aghia Paraskevi, 153 42 Athens, Greece. pectasid@otenet.gr
pubmed:publicationType
Journal Article